4/11
04:05 pm
rlay
Relay Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Relay Therapeutics to Participate in Upcoming Investor Conferences
3/13
02:55 am
rlay
Relay Therapeutics: Platform More Important Than Programs [Seeking Alpha]
Low
Report
Relay Therapeutics: Platform More Important Than Programs [Seeking Alpha]
2/28
05:30 am
rlay
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Low
Report
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
2/26
04:05 pm
rlay
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
Low
Report
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
2/24
09:36 am
rlay
Relay Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
High
Report
Relay Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
2/22
04:50 pm
rlay
Relay Therapeutics Inc (RLAY) Reports Full Year 2023 Financial Results and Corporate Highlights [Yahoo! Finance]
Medium
Report
Relay Therapeutics Inc (RLAY) Reports Full Year 2023 Financial Results and Corporate Highlights [Yahoo! Finance]
2/22
04:24 pm
rlay
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights [Yahoo! Finance]
Medium
Report
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights [Yahoo! Finance]
2/22
04:05 pm
rlay
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
Medium
Report
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
2/22
02:30 pm
rlay
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its price target raised by analysts at Stifel Nicolaus from $25.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its price target raised by analysts at Stifel Nicolaus from $25.00 to $30.00. They now have a "buy" rating on the stock.
2/15
04:05 pm
rlay
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
Low
Report
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024
2/15
11:53 am
rlay
Relay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Should You Buy? [Yahoo! Finance]
Medium
Report
Relay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Should You Buy? [Yahoo! Finance]
2/15
04:50 am
rlay
Relay Therapeutics, Inc. (RLAY) Moves 10.0% Higher: Will This Strength Last? [Yahoo! Finance]
Medium
Report
Relay Therapeutics, Inc. (RLAY) Moves 10.0% Higher: Will This Strength Last? [Yahoo! Finance]
2/12
10:15 pm
rlay
Relay Therapeutics: Tapping Into An Unmet Need At A High Price Tag [Seeking Alpha]
Medium
Report
Relay Therapeutics: Tapping Into An Unmet Need At A High Price Tag [Seeking Alpha]
2/1
04:05 pm
rlay
Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Low
Report
Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference